Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 8/2014

01-12-2014 | Original Paper

Predictors of coronary artery aneurysm after stent implantation in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Authors: Can Yucel Karabay, Gonenc Kocabay, Ahmet Guler, Vecih Oduncu, Taylan Akgun, Arzu Kalayci, Alev Kılıcgedik, Onur Tasar, Sedat Kalkan, Ayhan Erkol, Akin İzgi, Ali Metin Esen, Cevat Kirma

Published in: The International Journal of Cardiovascular Imaging | Issue 8/2014

Login to get access

Abstract

The clinical and angiographic predictors of coronary artery aneurysm (CAA) formation in patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) are not clear. This study aims to assess the predictors of CAA formation after primary PCI. 3,428 patients who underwent PCI for STEMI were enrolled. The average period of follow-up was mean 48 months (range 35–56 months) after PCI. During this time, 1,304 patients were underwent follow-up coronary angiography. CAA was detected in 21 patients (1.6 %). CAA occurred at the segment of stent implantation in all patients. The clinical and angiographic data were compared between patients with CAA group (n = 21) and without CAA group (n = 1,283). Patients who developed CAA had longer reperfusion time, higher high-sensitiviy C-reactive protein (hs-CRP) levels and neutrophil to lymphocyte ratio than those who had without CAA. Angiographically, CAA developed proximally located lesions and lesion length was significantly greater in patients with CAA than without CAA. Statin and beta-blocker discontinuation were found higher in stent-associated CAA. Every 1 mg/l increase in hs-CRP and implantation of drug eluting stent (DES) were independent predictor of CAA formation after STEMI. Baseline elevated inflammation status and DES implantation in the setting of STEMI may predict the CAA formation.
Literature
1.
go back to reference Aoki J, Kirtane A, Leon MB, Dangas G (2008) Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 1:14–21PubMedCrossRef Aoki J, Kirtane A, Leon MB, Dangas G (2008) Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 1:14–21PubMedCrossRef
2.
go back to reference Karabay CY, Kocabay G, Tasar O, Kalayci A, Guler A, Kirma C (2013) Evaluation of aneurysm after coronary stent implantation by optical coherence tomography. Kardiol Pol 71:659PubMedCrossRef Karabay CY, Kocabay G, Tasar O, Kalayci A, Guler A, Kirma C (2013) Evaluation of aneurysm after coronary stent implantation by optical coherence tomography. Kardiol Pol 71:659PubMedCrossRef
3.
go back to reference Yoshikawa D, Ishii H, Aoyama Y, Ichimiya H, Shimizu Y, Isobe S et al (2010) Optical coherence tomography images of a coronary artery aneurysm in an infarct-related artery 6 months after bare-metal stent implantation. JACC Cardiovasc Interv 3:1300–1302PubMedCrossRef Yoshikawa D, Ishii H, Aoyama Y, Ichimiya H, Shimizu Y, Isobe S et al (2010) Optical coherence tomography images of a coronary artery aneurysm in an infarct-related artery 6 months after bare-metal stent implantation. JACC Cardiovasc Interv 3:1300–1302PubMedCrossRef
4.
go back to reference Bajaj S, Parikh R, Hamdan A, Bikkina M (2010) Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review. Tex Heart Inst J 37:449–544PubMedCentralPubMed Bajaj S, Parikh R, Hamdan A, Bikkina M (2010) Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review. Tex Heart Inst J 37:449–544PubMedCentralPubMed
5.
go back to reference Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S (1997) Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 79:1104–1106PubMedCrossRef Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S (1997) Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 79:1104–1106PubMedCrossRef
6.
go back to reference Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705PubMedCrossRef Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701–705PubMedCrossRef
7.
go back to reference Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC et al (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115:1051–1058PubMedCrossRef Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC et al (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115:1051–1058PubMedCrossRef
8.
go back to reference Ahn CM, Hong BK, Kim JY, Min PK, Yoon YW, Lee BK et al (2010) Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation. Am Heart J 160:987–994PubMedCrossRef Ahn CM, Hong BK, Kim JY, Min PK, Yoon YW, Lee BK et al (2010) Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation. Am Heart J 160:987–994PubMedCrossRef
9.
go back to reference Feng T, Yundai C, Hongbin L, Lian C, Zhijun S, Jun G et al (2013) Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography. Int J Cardiovasc Imaging 29:1677–1683PubMedCentralPubMedCrossRef Feng T, Yundai C, Hongbin L, Lian C, Zhijun S, Jun G et al (2013) Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography. Int J Cardiovasc Imaging 29:1677–1683PubMedCentralPubMedCrossRef
10.
go back to reference Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R et al (2009) Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 53:2053–2060PubMedCrossRef Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R et al (2009) Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 53:2053–2060PubMedCrossRef
11.
go back to reference Wang KY, Ting CT, St John Sutton M, Chen YT (1999) Coronary artery aneurysms: a 25-patient study. Catheter Cardiovasc Interv 48:31–38PubMedCrossRef Wang KY, Ting CT, St John Sutton M, Chen YT (1999) Coronary artery aneurysms: a 25-patient study. Catheter Cardiovasc Interv 48:31–38PubMedCrossRef
12.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
13.
go back to reference Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of Infarcting Myocardium Early II trial substudy. Circulation 102:2031–2037PubMedCrossRef Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of Infarcting Myocardium Early II trial substudy. Circulation 102:2031–2037PubMedCrossRef
14.
go back to reference Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555PubMedCrossRef Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501–2555PubMedCrossRef
15.
go back to reference Gibson CM, de Lemos JA, Murphy SA et al (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:2550–2554PubMedCrossRef Gibson CM, de Lemos JA, Murphy SA et al (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:2550–2554PubMedCrossRef
16.
go back to reference Yip HK, Chen MC, Chang HW et al (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow flow and no-reflow. Chest 122:1322–1332PubMedCrossRef Yip HK, Chen MC, Chang HW et al (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow flow and no-reflow. Chest 122:1322–1332PubMedCrossRef
17.
go back to reference Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888PubMedCrossRef Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888PubMedCrossRef
18.
19.
go back to reference Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S (1997) Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 79:1104–1106PubMedCrossRef Slota PA, Fischman DL, Savage MP, Rake R, Goldberg S (1997) Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol 79:1104–1106PubMedCrossRef
20.
go back to reference Levisay JP, Roth RM, Schatz RA (2008) Coronary artery aneurysm formation after drug-eluting stent implantation. Cardiovasc Revasc Med 9:284–287PubMedCrossRef Levisay JP, Roth RM, Schatz RA (2008) Coronary artery aneurysm formation after drug-eluting stent implantation. Cardiovasc Revasc Med 9:284–287PubMedCrossRef
21.
go back to reference Akin I, Kische S, Rehders TC, Schneider H, Turan GR, Kleinfeldt T et al (2011) Very late coronary aneurysm formation with subsequent stent thrombosis secondary to drug-eluting stent. Chin Med J (Engl) 124:3427–3429 Akin I, Kische S, Rehders TC, Schneider H, Turan GR, Kleinfeldt T et al (2011) Very late coronary aneurysm formation with subsequent stent thrombosis secondary to drug-eluting stent. Chin Med J (Engl) 124:3427–3429
22.
go back to reference Rab ST, King SB 3rd, Roubin GS, Carlin S, Hearn JA, Douglas JS Jr (1991) Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 18:1524–1528PubMedCrossRef Rab ST, King SB 3rd, Roubin GS, Carlin S, Hearn JA, Douglas JS Jr (1991) Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 18:1524–1528PubMedCrossRef
23.
go back to reference Bavry AA, Chiu JH, Jefferson BK, Karha J, Bhatt DL, Ellis SG et al (2007) Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med 146:230–232PubMedCrossRef Bavry AA, Chiu JH, Jefferson BK, Karha J, Bhatt DL, Ellis SG et al (2007) Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med 146:230–232PubMedCrossRef
24.
go back to reference Virmani R, Kolodgie FD, Farb A (2004) Drug-eluting stents: are they really safe? Am Heart Hosp J 2:85–88PubMedCrossRef Virmani R, Kolodgie FD, Farb A (2004) Drug-eluting stents: are they really safe? Am Heart Hosp J 2:85–88PubMedCrossRef
25.
go back to reference Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D et al (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294:1215–1223PubMedCrossRef Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D et al (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294:1215–1223PubMedCrossRef
26.
go back to reference Vassilev D, Hazan M, Dean L (2012) Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report. Catheter Cardiovasc Interv 80:1223–1226PubMedCrossRef Vassilev D, Hazan M, Dean L (2012) Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report. Catheter Cardiovasc Interv 80:1223–1226PubMedCrossRef
27.
go back to reference Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202PubMedCrossRef Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202PubMedCrossRef
28.
go back to reference Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG et al (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46:1002–1005PubMedCrossRef Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG et al (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46:1002–1005PubMedCrossRef
30.
go back to reference Ozden K, Sengül C, Fotbolcu H, Dindar I (2012) A late coronary aneurysm after sirolimus stent implantation which was treated with coronary graft stent]. Turk Kardiyol Dern Ars 40:440–443PubMedCrossRef Ozden K, Sengül C, Fotbolcu H, Dindar I (2012) A late coronary aneurysm after sirolimus stent implantation which was treated with coronary graft stent]. Turk Kardiyol Dern Ars 40:440–443PubMedCrossRef
31.
go back to reference Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A et al (2004) Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 147:42–48PubMedCrossRef Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A et al (2004) Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 147:42–48PubMedCrossRef
32.
go back to reference Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C (2009) Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 206:335–339PubMedCrossRef Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C (2009) Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 206:335–339PubMedCrossRef
33.
go back to reference Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL (2006) Usefulness of an elevated neutrophil -to-lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97:993–996PubMedCrossRef Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL (2006) Usefulness of an elevated neutrophil -to-lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97:993–996PubMedCrossRef
34.
go back to reference Wilson WR, Evans J, Bell PR, Thompson MM (2005) HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 30:259–262PubMedCrossRef Wilson WR, Evans J, Bell PR, Thompson MM (2005) HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 30:259–262PubMedCrossRef
35.
go back to reference Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S (2006) Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97:279–280PubMedCrossRef Sukhija R, Aronow WS, Sandhu R, Kakar P, Babu S (2006) Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97:279–280PubMedCrossRef
36.
go back to reference Ozbay Y, Akbulut M, Balin M, Kayancicek H, Baydas, Korkmaz H (2007) The level of hs-CRP in coronary artery ectasia and its response to statin and an- giotensin-converting enzyme inhibitor treatment. Med Inflamm 2007:89649CrossRef Ozbay Y, Akbulut M, Balin M, Kayancicek H, Baydas, Korkmaz H (2007) The level of hs-CRP in coronary artery ectasia and its response to statin and an- giotensin-converting enzyme inhibitor treatment. Med Inflamm 2007:89649CrossRef
Metadata
Title
Predictors of coronary artery aneurysm after stent implantation in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Authors
Can Yucel Karabay
Gonenc Kocabay
Ahmet Guler
Vecih Oduncu
Taylan Akgun
Arzu Kalayci
Alev Kılıcgedik
Onur Tasar
Sedat Kalkan
Ayhan Erkol
Akin İzgi
Ali Metin Esen
Cevat Kirma
Publication date
01-12-2014
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 8/2014
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-014-0503-z

Other articles of this Issue 8/2014

The International Journal of Cardiovascular Imaging 8/2014 Go to the issue